placeholder image
A. Al-Janadi All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Phase Ib/II clinical trial of pembrolizumab with bevacizumab for metastatic renal cell carcinoma: BTCRC-GU14-003. 
    Journal of Clinical Oncology. 2020
    • Contact
    full name
  • A. Al-Janadi
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration